Cordlife Group (SG:P8A) has released an update.
Cordlife Group Limited has reported that following an investigation by the Ministry of Health, five of their six cryogenic storage tanks have been classified as ‘Low-Risk’, showing no adverse effects from temperature deviations and maintaining cell viability in approximately 13,700 cord blood units for active clients. The issues were attributed to minor operational errors such as displacement of temperature probes and incorrect data mapping. This comes after a mandated suspension of new collections and tests by the Ministry, with ongoing investigations into compliance with healthcare regulations.
For further insights into SG:P8A stock, check out TipRanks’ Stock Analysis page.
